The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,028.00
Bid: 2,030.00
Ask: 2,032.00
Change: 26.00 (1.30%)
Spread: 2.00 (0.099%)
Open: 2,014.00
High: 2,036.00
Low: 2,010.00
Prev. Close: 2,002.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks end volatile April on high note

Fri, 29th Apr 2022 17:01

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed.

The FTSE 100 index closed up 35.36 points, or 0.5%, at 7,544.55 - ending the week overall up 0.3%. Over the month the UK flagship index lost 0.5%.

The mid-cap FTSE 250 index ended up 89.09 points, or 0.4%, at 20,708.71 and lost 0.8% over the past 5 days.

The AIM All-Share index finished up 7.40 points, or 0.7%, at 1,022.26 - closing out the week 2.3% lower.

The Cboe UK 100 index closed up 0.5% at 750.31. The Cboe 250 closed down 0.6% at 18,265.99, and the Cboe Small Companies closed down 0.2% at 15,139.35.

In mainland Europe, the CAC 40 stock index in Paris ended up 0.4%, while the DAX 40 in Frankfurt up 0.8%.

IG Group's Chris Beauchamp said: "A gulf has opened between Europe and the US, as the former rally while the latter drops back. US stocks enjoyed such a strong day yesterday that some caution was inevitable, while the mixed picture following US tech earnings and the contraction in US GDP isn't helping sentiment on Wall Street.

"But higher commodity prices have helped stabilise industrial European stocks, and crucially the magic promise of Chinese stimulus has appeared, pushing up commodity prices and giving stocks across the continent a lift."

As China's lockdowns continue and new infections continue to spread in Beijing, the central government outlined wide-ranging economic stimulus plans to temper expected losses. The government will subsidise businesses, pausing unemployment insurance payments if companies avoid mass layoffs, as well as electricity and internet charges.

In the FTSE 100, Smurfit Kappa closed up 4.3% after the paper and packaging firm reported first quarter earnings growth despite headwinds at the start of 2022.

The Irish firm reported year-on-year revenue growth of 33% to EUR3.02 billion in the first quarter of 2022, with earnings before interest, tax, depreciation and amortisation rising at the same rate to EUR514 million. Its Ebitda margin was flat at 17% despite inflationary pressures in the period.

Rivals Mondi and DS Smith rose 3.4% and 1.6% respectively in a positive read-across.

Pearson closed up 1.9% after the educational materials publisher provided a positive update on first quarter trading, while also announcing a new acquisition.

Pearson has agreed to buy Mondly, an online language learning platform. It provided no financial details, but said it expects the purchase to accelerate revenue growth for its English Language Learning division from 2023 onward. It expects mid-teens margins for the division by 2025.

Turning to its own recent trading, Pearson reported underlying sales growth of 7% in the first quarter. It reaffirmed its guidance for adjust operating profit in 2022.

Pearson added that its GBP350 million share buyback programme has begun, with GBP75 million already completed.

AstraZeneca added 0.5% after the Anglo-Swedish drugmaker reported a sharp rise in first-quarter revenue.

Quarterly pretax profit shrank 66% to USD553 million from USD1.61 billion a year ago. Revenue rose by 56% to USD11.39 billion from USD7.32 billion. Revenue from its oncology arm grew by 21% to USD3.64 billion from USD3.02 billion.

AstraZeneca completed its USD39 billion takeover of Boston-based rare diseases firm Alexion Pharmaceuticals in July last year, helping to boost its top line.

In the quarter, AstraZeneca generated USD1.09 billion in sales from its Covid-19 vaccine Vaxzevria, ups sharply from a year prior. Contracts with the vaccine are expected to complete delivery by the second half of the year, the firm added.

Astra backed annual guidance. It tips revenue to rise "by a high teens percentage" and core EPS to climb by a "mid-to-high twenties percentage".

At the other end of the large-caps, Hikma Pharmaceuticals ended the worst performer, down 7.2%, after the drugmaker noted its Generics business has experienced some headwinds.

Hikma explained its Generics business has been hurt by increased competition and a challenging pricing environment, resulting in a "slow" start to the year.

Nonetheless, Hikma said it continues to expect full-year Generics revenue growth between 8% to 10%, though it noted this would likely be weighted towards the second half of the year.

Conversely, Hikma reported its Branded business is performing well.

Vodafone closed down 4.3% after Bank of America downgraded the telecommunications firm to 'neutral' from 'buy'.

NatWest Group lost 2.2% despite reporting largely positive first-quarter numbers.

In the three months to March 31, the Edinburgh-headquartered bank recorded an operating pretax profit of GBP1.25 billion, surging 41% from GBP885 million in the same period a year prior. Attributable profit rose 36% to GBP841 million from GBP620 million.

NatWest - formerly Royal Bank of Scotland - saw total income rise 17% to GBP3.03 billion from GBP2.59 billion. Net interest income rose to GBP2.05 billion from GBP1.86 billion, while non-interest income increased to GBP982 million from GBP727 million.

Looking ahead, NatWest said its 2022 income excluding notable items will be "comfortably" above GBP11.0 billion in the 'go-forward group' - advancing at least 4.7% from total income of GBP10.51 billion in 2021.

In the FTSE 250, Johnson Matthey ended the standout performer, up 19%. A regulatory filing on Friday showed industrial investor Standard Investments LLC has built a 5.2% stake in the specialist chemicals firm. Standard Investments is based in New York.

The pound was quoted at USD1.2568 at the London equities close, up from USD1.2458 at the close Thursday.

The euro stood at USD1.0547 at the European equities close, up from USD1.0524 late Thursday. Against the yen, the dollar was trading at JPY129.68, down sharply from JPY131.00.

On the continent, the eurozone's economy grew at a slower pace than expected in the first quarter of 2022, while separate data showed inflation picked up slightly in April.

According to Eurostat, eurozone gross domestic product grew 0.2% quarter-on-quarter in the first three months of 2022. The figure fell short of an FXStreet cited estimate of 0.3% growth. In the fourth quarter of 2021, GDP had expanded by 0.3%.

Annually, first quarter economic growth from the single currency area was 5.0%, accelerating from the fourth quarter's 4.7% rise. Annual growth came in line with FXStreet cited consensus.

Separate figures from Eurostat showed inflation accelerated to another record high in April, as expected. The eurozone annual inflation rate for April was 7.5%, an uptick from 7.4% in March. The April figure was in line with FXStreet cited consensus. On a monthly basis, consumer prices grew 0.6%.

New York was sharply lower at the London equities close amid disappointing corporate earnings reports.

The DJIA was down 1.1%, the S&P 500 index down 1.6% and the Nasdaq Composite down 1.7%.

Amazon.com plunged 13% after reporting its first quarterly loss since 2015 as sales growth slowed while the company faces challenges with rising costs.

Intel was down 5.6% after the semiconductor maker warned the global chip shortage will remain a challenge for the industry until at least 2024, particularly in areas such as foundry capacity and tool availability.

Brent oil was quoted at USD110.30 a barrel at the equities close, up sharply from USD106.55 at the close Thursday.

Gold stood at USD1,906.75 an ounce at the London equities close, higher against USD1,887.75 late Thursday.

The economic events calendar on Monday has manufacturing PMI readings from the Germany at 0855 BST, the eurozone at 0900 BST and US at 1445 BST. Financial markets in the UK are closed on Monday for the Early May bank holiday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
4 Aug 2023 09:39

LONDON BROKER RATINGS: Jefferies raises John Wood to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
3 Aug 2023 15:45

UK dividends calendar - next 7 days

Friday 4 August 
Burberry Group PLCdividend payment date
Bytes Technology Group PLCdividend payment date
Bytes Technology Group PLCspecial dividend payment date
CC Japan Income & Growth Trust PLCdividend payment date
CT UK High Income Trust PLCdividend payment date
Ferguson PLCdividend payment date
Global Smaller Cos Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan European Discovery Trust PLCdividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Mitie Group PLCdividend payment date
NewRiver REIT PLCdividend payment date
Norcros PLCdividend payment date
North American Income Trust PLCdividend payment date
Palace Capital PLCdividend payment date
Premier Miton Group PLCdividend payment date
Regional REIT Ltddividend payment date
Schroder UK Mid Cap Fund PLCdividend payment date
Supermarket Income REIT PLCdividend payment date
Twentyfour Income Fund Ltddividend payment date
Value & Indexed Property Income Trust PLCdividend payment date
Vodafone Group PLCdividend payment date
Vp PLCdividend payment date
Workspace Group PLCdividend payment date
Monday 7 August 
no events scheduled 
Tuesday 8 August 
no events scheduled 
Wednesday 9 August 
National Grid PLCdividend payment date
Record PLCdividend payment date
Thursday 10 August 
abrdn New Dawn Investment Trust PLCex-dividend payment date
Alternative Income REIT PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
Avon Protection PLCex-dividend payment date
Barclays PLCex-dividend payment date
BP PLCex-dividend payment date
Domino's Pizza Group PLCex-dividend payment date
Fresnillo PLCex-dividend payment date
Greencoat Renewables PLCex-dividend payment date
Greencoat UK Wind PLCex-dividend payment date
Halfords Group PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
HSBC Holdings PLCex-dividend payment date
IMI PLCex-dividend payment date
Impax Environmental Markets PLCex-dividend payment date
Informa PLCex-dividend payment date
IP Group PLCex-dividend payment date
Irish Residential Properties REIT PLCex-dividend payment date
Lindsell Train Investment Trust PLCex-dividend payment date
LMS Capital PLCex-dividend payment date
Majedie Investments PLCex-dividend payment date
Man Group PLCex-dividend payment date
NatWest Group PLCex-dividend payment date
PayPoint PLCex-dividend payment date
Pearson PLCex-dividend payment date
PRS REIT PLCex-dividend payment date
Quartix Technologies PLCex-dividend payment date
Reach PLCex-dividend payment date
Residential Secure Income PLCex-dividend payment date
Rio Tinto PLCex-dividend payment date
Safestore Holdings PLCdividend payment date
Scottish American Investment Co PLCex-dividend payment date
Segro PLCex-dividend payment date
Shell PLCex-dividend payment date
Speedy Hire PLCex-dividend payment date
Spirent Communications PLCex-dividend payment date
Standard Chartered PLCex-dividend payment date
Target Healthcare REIT PLCex-dividend payment date
Taylor Maritime Investments Ltdex-dividend payment date
Treatt PLCdividend payment date
Tritax Big Box REIT PLCex-dividend payment date
Vanquis Banking Group PLCex-dividend payment date
Vh Global Sustainable Energy Opportunities PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Aug 2023 09:28

Hikma posts higher interim revenue; ups guidance for Generics business

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday said it expects a higher full year performance from its Generics business amid interim revenue growth, but reported a drop in profit.

Read more
3 Aug 2023 07:51

Hikma lifts guidance for generics business

(Sharecast News) - Hikma Pharmaceuticals lifted annual revenue and margin guidance for its generics business as first-half core operating profit rose 35%.

Read more
27 Jul 2023 15:40

UK earnings, trading statements calendar - next 7 days

Friday 28 July 
AstraZeneca PLCHalf Year Results
AIB Group PLCHalf Year Results
IMI PLCHalf Year Results
Impellam Group PLCHalf Year Results
International Consolidated Airlines Group SAHalf Year Results
Intertek Group PLCHalf Year Results
Jardine Matheson Holdings LtdHalf Year Results
NatWest Group PLCHalf Year Results
PayPoint PLCFull Year Results
PayPoint PLCTrading Statement
Rightmove PLCHalf Year Results
Standard Chartered PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
Vanquis Banking Group PLCHalf Year Results
YouGov PLCTrading Statement
Monday 31 July 
Bank of Ireland Group PLCHalf Year Results
GlobalData PLCHalf Year Results
Hutchmed (China) LtdHalf Year Results
Pearson PLCHalf Year Results
Pod Point Group Holdings PLCHalf Year Results
Quartix Technologies PLCHalf Year Results
Ricardo PLCTrading Statement
Senior PLCHalf Year Results
Spectris PLCHalf Year Results
Tuesday 1 August 
BP PLCHalf Year Results
Coats Group PLCHalf Year Results
Diageo PLCFull Year Results
Domino's Pizza Group PLCHalf Year Results
Filtronic PLCFull Year Results
Fresnillo PLCHalf Year Results
Greggs PLCHalf Year Results
HSBC Holdings PLCHalf Year Results
International Personal Finance PLCHalf Year Results
Keller Group PLCHalf Year Results
Man Group PLCHalf Year Results
Metro Bank PLCHalf Year Results
NWF Group PLCFull Year Results
Robert Walters PLCHalf Year Results
Staffline Group PLCHalf Year Results
System1 Group PLCFull Year Results
Travis Perkins PLCHalf Year Results
Virgin Wines UK PLCTrading Statement
Weir Group PLCHalf Year Results
XP Power LtdHalf Year Results
Wednesday 2 August 
BAE Systems PLCHalf Year Results
ConvaTec Group PLCHalf Year Results
Direct Line Insurance Group PLCHalf Year Results
Endeavour Mining PLCHalf Year Results
Ferrexpo PLCHalf Year Results
Haleon PLCHalf Year Results
Genel Energy PLCHalf Year Results
Ibstock PLCHalf Year Results
IP Group PLCHalf Year Results
Kerry Group PLCHalf Year Results
Permanent TSB Group Holdings PLCHalf Year Results
Smurfit Kappa Group PLCHalf Year Results
Spirent Communications PLCHalf Year Results
Taylor Wimpey PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Thursday 3 August 
Coca-Cola Europacific Partners PLCHalf Year Results
Helios Towers PLCHalf Year Results
Hikma Pharmaceuticals PLCHalf Year Results
Irish Residential Properties REIT PLCHalf Year Results
London Stock Exchange Group PLCHalf Year Results
Mears Group PLCHalf Year Results
Mondi PLCTrading Statement
Morgan Sindall Group PLCHalf Year Results
Next PLCTrading Statement
Omega Diagnostics Group PLCFull Year Results
Pantheon International PLCFull Year Results
Pets At Home Group PLCQ1 Results
Rolls-Royce Holdings PLCHalf Year Results
ScS Group PLCTrading Statement
Serco Group PLCHalf Year Results
Shaftesbury Capital PLCHalf Year Results
Smith & Nephew PLCHalf Year Results
Tritax Big Box REIT PLCHalf Year Results
TT Electronics PLCHalf Year Results
Walker Crips Group PLCFull Year Results
Wizz Air Holdings PLCQ1 Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
20 Jul 2023 17:08

Commodity-heavy FTSE 100 lifted by Anglo American, China stimulus hopes

Anglo American shines after production update

*

Read more
20 Jul 2023 11:43

Hikma, Fresenius shares rally after tornado hits rival Pfizer's U.S. plant

LONDON, July 20 (Reuters) - Shares in UK pharmaceutical company Hikma rose by the most in 10 months on Thursday after tornado damage to a U.S. facility owned by competitor Pfizer boosted other drugmakers' stock.

Read more
20 Jul 2023 09:54

Shares in Pfizer rivals Hikma, Fresenius rally after tornado hits factory

LONDON, July 20 (Reuters) - Shares in UK pharmaceutical company Hikma rose by the most in 10 months on Thursday, hitting an 18-month high, following news of tornado damage to a U.S. facility owned by competitor Pfizer, which boosted other drugmakers' stock.

Read more
20 Jul 2023 08:53

Hikma surges after tornado damages Pfizer injectables plant

(Sharecast News) - Hikma Pharmaceuticals surged on Thursday, with traders pointing to news that a major Pfizer injectables plant in North Carolina was hit by a tornado and heavily damaged on Wednesday.

Read more
12 Jul 2023 09:27

LONDON BROKER RATINGS: UBS raises AstraZeneca; RBC cuts Bunzl

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
8 Jun 2023 12:03

Director dealings: Hikma non-exec invests, LSE Group share buyback rolls on

(Sharecast News) - Hikma Pharmaceuticals was among those on the list of director buys on Thursday, after a non-executive director added almost £27k worth of shares to his holding.

Read more
22 May 2023 09:23

LONDON BROKER RATINGS: Citigroup cuts Sainsbury to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 May 2023 09:29

LONDON BROKER RATINGS: RBC raises Intertek; Davy likes Greencoat UK

(Alliance News) - The following London-listed shares received analyst recommendations xxxxday morning:

Read more
3 May 2023 16:16

Broker tips: HSBC, Hikma, Pearson

(Sharecast News) - Berenberg upgraded HSBC to 'buy' from 'hold' on Wednesday, keeping the price target at 780p, as it said the bank's return on tangible equity of around 13% and attractive growth potential are undervalued.

Read more
3 May 2023 12:56

RBC Capital lifts Hikma price target, reiterates 'outperform'

(Sharecast News) - RBC Capital Markets lifted its price target on Hikma Pharmaceuticals on Wednesday to 2,050p from 1,950p as it reiterated its 'outperform' rating.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.